Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions (Front. Immunol., (2022), 13, 893648, 10.3389/fimmu.2022.893648)

Autor: Schriek, Angela I., van Haaren, Marlies M., Poniman, Meliawati, Dekkers, Gillian, Bentlage, Arthur E. H., Grobben, Marloes, Vidarsson, Gestur, Sanders, Rogier W., Verrips, Theo, Geijtenbeek, Teunis B. H., Heukers, Raimond, Kootstra, Neeltje A., de Taeye, Steven W., van Gils, Marit J.
Přispěvatelé: Experimental Immunology, Graduate School, AII - Infectious diseases, Medical Microbiology and Infection Prevention, Infectious diseases, AII - Cancer immunology, APH - Aging & Later Life, Molecular cell biology and Immunology
Jazyk: angličtina
Rok vydání: 2022
Předmět:
Zdroj: Frontiers in immunology, 13:1091668. Frontiers Media S.A.
Frontiers in Immunology, 13:1091668
ISSN: 1664-3224
Popis: In the published article, there was an error in the Funding statement. The funder was mentioned as AIDSfonds and Aids fonds instead of Aidsfonds. The correct Funding statement appears below. Funding This work was supported by HealthHolland/Aidsfonds: LSHM19101/P-44802, by HealthHolland/AMC: 2019-1167 and the AMC Fellowship from Amsterdam UMC received by MJG. ST is supported by Young investigator grant P-53301 Aidsfonds. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Databáze: OpenAIRE